 Intercept Pharmaceuticals, Inc. NASDAQ:ICPT Q2 2022 Results Conference Call August 2, 2022 8:30 AM ET Company Participants Nareg Sagherian - ED, IR Jerry Durso - President and CEO Linda Richardson - Chief Commercial Officer Dr. Michelle Berrey - President of Research Development and Chief Medical Officer Andrew Saik - CFO Conference Call Participants Yasmeen Rahimi - Piper Sandler Kelechi Chikere - Jefferies Steve Seedhouse - Raymond James Thomas Smith - SVB Securities Jon Wolleben - JMP Securities Mayank Mamtani - B. Riley Securities Ellie Merle - UBS Matt Dellatorre - Goldman Sachs Operator Hello. 